Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 20, 2005

Circulation. 2005
Published online before print June 20, 2005, doi: 10.1161/CIRCULATIONAHA.104.510073
A more recent version of this article appeared on June 28, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
111/25/3443    most recent
CIRCULATIONAHA.104.510073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lutgens, E.
Right arrow Articles by Daemen, M. J.A.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lutgens, E.
Right arrow Articles by Daemen, M. J.A.P.
Related Collections
Right arrow Pathophysiology
Right arrow Gene expression
Right arrow Genomics

Submitted on September 30, 2004
Revised on February 7, 2005
Accepted on March 29, 2005

Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines. Validation Using a Novel Monocyte Chemoattractant Protein Monoclonal Antibody

Esther Lutgens MD, PhD*, Birgit Faber PhD, Kitty Schapira BSc, Chris T.A. Evelo PhD, Rachel van Haaften PhD, Sylvia Heeneman PhD, Kitty B.J.M. Cleutjens PhD, Ann Pascale Bijnens PhD, Linda Beckers BSc, J. Gordon Porter PhD, Charles R. Mackay PhD, Paul Rennert PhD, Veronique Bailly PhD, Matthew Jarpe PhD, Brian Dolinski PhD, Victor Koteliansky MD, PhD, Tony de Fougerolles PhD, and Mat J.A.P. Daemen MD, PhD

From the Departments of Pathology (E.L., B.F., K.S., S.H., K.B.J.M.C., A.P.B., L.B., M.J.A.P.D.) and Bioinformatics (C.T.A.E., R.v.H.), Cardiovascular Research Institute Maastricht, University of Maastricht, Maastricht, the Netherlands; Incyte Corporation, Palo Alto, Calif (J.G.P.); Arthritis and Inflammation Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia (C.R.M.); and Biogen-Idec Inc, Cambridge, Mass (P.R., V.B., M.J., B.D., V.K., T.d.F.). Drs de Fougerolles and Koteliansky are currently affiliated with Alnylam Pharmaceuticals, Cambridge, Mass.

* To whom correspondence should be addressed. E-mail: e.lutgens{at}path.unimaas.nl.

Background--Pathological aspects of atherosclerosis are well described, but gene profiles during atherosclerotic plaque progression are largely unidentified.

Methods and Results--Microarray analysis was performed on mRNA of aortic arches of ApoE-/- mice fed normal chow (NC group) or Western-type diet (WD group) for 3, 4.5, and 6 months. Of 10 176 reporters, 387 were differentially (>2x) expressed in at least 1 group compared with a common reference (ApoE-/-, 3- month NC group). The number of differentially expressed genes increased during plaque progression. Time-related expression clustering and functional grouping of differentially expressed genes suggested important functions for genes involved in inflammation (especially the small inducible cytokines monocyte chemoattractant protein [MCP]-1, MCP-5, macrophage inflammatory protein [MIP]-1{alpha}, MIP-1{beta}, MIP-2, and fractalkine) and matrix degradation (cathepsin-S, matrix metalloproteinase-2/12). Validation experiments focused on the gene cluster of small inducible cytokines. Real-time polymerase chain reaction revealed a plaque progression-dependent increase in mRNA levels of MCP-1, MCP-5, MIP-1{alpha}, and MIP-1{beta}. ELISA for MCP-1 and MCP-5 showed similar results. Immunohistochemistry for MCP-1, MCP-5, and MIP-1{alpha} located their expression to plaque macrophages. An inhibiting antibody for MCP-1 and MCP-5 (11K2) was designed and administered to ApoE-/- mice for 12 weeks starting at the age of 5 or 17 weeks. 11K2 treatment reduced plaque area and macrophage and CD45+ cell content and increased collagen content, thereby inducing a stable plaque phenotype.

Conclusions--Gene profiling of atherosclerotic plaque progression in ApoE-/- mice revealed upregulation of the gene cluster of small inducible cytokines. Further expression and in vivo validation studies showed that this gene cluster mediates plaque progression and stability.


Key words: atherosclerosis • genes • inflammation




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. D. Frutkin, G. Otsuka, A. Stempien-Otero, C. Sesti, L. Du, M. Jaffe, H. L. Dichek, C. J. Pennington, D. R. Edwards, M. Nieves-Cintron, et al.
TGF-{beta}1 Limits Plaque Growth, Stabilizes Plaque Structure, and Prevents Aortic Dilation in Apolipoprotein E-Null Mice
Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1251 - 1257.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Magnone, S. Bruzzone, L. Guida, G. Damonte, E. Millo, S. Scarfi, C. Usai, L. Sturla, D. Palombo, A. De Flora, et al.
Abscisic Acid Released by Human Monocytes Activates Monocytes and Vascular Smooth Muscle Cell Responses Involved in Atherogenesis
J. Biol. Chem., June 26, 2009; 284(26): 17808 - 17818.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. D. N'Guessan, F. Riediger, K. Vardarova, S. Scharf, J. Eitel, B. Opitz, H. Slevogt, W. Weichert, A. C. Hocke, B. Schmeck, et al.
Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 380 - 386.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zernecke, E. Shagdarsuren, and C. Weber
Chemokines in Atherosclerosis: An Update
Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1897 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Aukrust, B. Halvorsen, A. Yndestad, T. Ueland, E. Oie, K. Otterdal, L. Gullestad, and J. K. Damas
Chemokines and Cardiovascular Risk
Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1909 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Schmeck, W. Beermann, P. D. N'Guessan, A. C. Hocke, B. Opitz, J. Eitel, Q. T. Dinh, M. Witzenrath, M. Krull, N. Suttorp, et al.
Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
Circ. Res., April 25, 2008; 102(8): 888 - 895.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. G. Frangogiannis
The Prognostic Value of Monocyte Chemoattractant Protein-1/CCL2 in Acute Coronary Syndromes
J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2125 - 2127.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. A. Ashley, J. M. Spin, R. Tabibiazar, and T. Quertermous
Frontiers in Nephrology: Genomic Approaches to Understanding the Molecular Basis of Atherosclerosis
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2853 - 2862.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. S. Wang, E. E. Schadt, H. Wang, X. Wang, L. Ingram-Drake, W. Shi, T. A. Drake, and A. J. Lusis
Identification of Pathways for Atherosclerosis in Mice: Integration of Quantitative Trait Locus Analysis and Global Gene Expression Data
Circ. Res., August 3, 2007; 101(3): e11 - e30.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Nakazawa, T. Hisatomi, C. Nakazawa, K. Noda, K. Maruyama, H. She, A. Matsubara, S. Miyahara, S. Nakao, Y. Yin, et al.
From the Cover: Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis
PNAS, February 13, 2007; 104(7): 2425 - 2430.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. H. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi, and B. J. Petrof
Toll-Like Receptors Differentially Regulate CC and CXC Chemokines in Skeletal Muscle via NF-{kappa}B and Calcineurin
Infect. Immun., December 1, 2006; 74(12): 6829 - 6838.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
C. Reid, M. Rushe, M. Jarpe, H. van Vlijmen, B. Dolinski, F. Qian, T. G. Cachero, H. Cuervo, M. Yanachkova, C. Nwankwo, et al.
Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody
Protein Eng. Des. Sel., July 1, 2006; 19(7): 317 - 324.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke, July 1, 2006; 37(7): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. B. de Haan, P. K. Witting, N. Stefanovic, J. Pete, M. Daskalakis, I. Kola, R. Stocker, and J. J. Smolich
Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet
J. Lipid Res., June 1, 2006; 47(6): 1157 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.P.J.J. Bijnens, E. Lutgens, T. Ayoubi, J. Kuiper, A.J. Horrevoets, and M.J.A.P. Daemen
Genome-Wide Expression Studies of Atherosclerosis: Critical Issues in Methodology, Analysis, Interpretation of Transcriptomics Data
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1226 - 1235.
[Abstract] [Full Text] [PDF]